<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04726722</url>
  </required_header>
  <id_info>
    <org_study_id>2020-00935</org_study_id>
    <nct_id>NCT04726722</nct_id>
  </id_info>
  <brief_title>Evaluation of a Personcentered Internet-based CBT Program for Stress, Anxiety and Depressive Symptoms in Patients With Cardiovascular Disease</brief_title>
  <official_title>Evaluation of an Adaptable and Personcentered Internet-based CBT Program Aimed to Treat Stress, Anxiety and Depressive Symptoms in Patients With Cardiovascular Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Linkoeping</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Linkoeping</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate a nine-week adaptable and person-centred I-CBT program that can be directed&#xD;
      towards stress, anxiety and depressive symptoms in persons with CVD.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All patients diagnosed as CVD (i.e. diagnosis Ischemia (ICD-code I20., I25.), Heart Failure&#xD;
      (ICD-code I50., I42.) or Arrhythmia (ICD-code I48, I49, DF016) and who received care in the&#xD;
      last 12 months at hospitals in the south-east of Sweden will be contacted by letter with&#xD;
      information about the study.&#xD;
&#xD;
      Participants who are interested are invited to visit our website for more information,&#xD;
      registration and provision of informed consent. After registration, participants will respond&#xD;
      to questions about demographics, medical history, stress, anxiety and depressive symptoms on&#xD;
      the website. Inclusion or exclusion will be assessed by a group consisting of a psychologist,&#xD;
      cardiology specialist nurse and a psychiatry specialist nurse.&#xD;
&#xD;
      Before final inclusion and randomization eligible participants will be contacted for a&#xD;
      telephone interview held by the study nurses.&#xD;
&#xD;
      Included (n=400) participants will, on our website (www.xxxxxx), complete the baseline study&#xD;
      questionnaires and then be randomized according to a 2 x2 factorial design.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 2022</start_date>
  <completion_date type="Anticipated">June 2026</completion_date>
  <primary_completion_date type="Anticipated">June 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <intervention_model_description>2 x 2</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in stress from baseline to 9 weeks on the 10 item Perceived Stress Scale</measure>
    <time_frame>From baseline to 9 weeks at the end of the intervention.</time_frame>
    <description>The 10-item Perceived Stress Scale is a valideted self-report of Stress. The instreument measures the degree to which individuals perceives their life situations as stressful. The 10 items are rated on a 5 point scale and higher scores means more stress</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in anxiety from baseline to 9 weeks on the 7-item Generalized Anxiety Disorder Scale.</measure>
    <time_frame>From baseline to 9 weeks at the end of the intervention.</time_frame>
    <description>General Anxiety Disorder scale is validagted self-resport that measure symptoms of general anxiety during the last two weeks. The 7-items range from 0 (not bothered at all) to 3 (nearly every day). A higher score indicate more anxiety and the cut-off 5 suggests at least mild anxiety.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in depressive symptoms from baseline to 9 weeks on the 9 item Patient Health Questionnaire.</measure>
    <time_frame>From baseline to 9 weeks at the end of the intervention.</time_frame>
    <description>The 9-item Patient Health Questionnaire is a validated self-report that measure depressive symtpoms during the last two weeks. Each item is answered on a four graded scale where 0 means that the person not is affected and 3 where the person is affected several Days to almost every day. Higher numbers represents higher levels of depressive symptoms. A cut-off &gt;5 represents at least mild depression.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Cardiovascular Disease</condition>
  <condition>Psychological Distress</condition>
  <arm_group>
    <arm_group_label>Design of the CBT treatment content</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient determined CBT content (i.e. person-centered) vs. therapist determined I-CBT content</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control of support and feedback</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient-controlled support and feedback (person-centred) vs. therapist -controlled.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>internet-based cognitive behavioral theraphy</intervention_name>
    <description>When determining the content of the I-CBT program, the participants and therapist will be allowed to choose from a library of treatment modules.&#xD;
Therapist controlled support and feedback are given weekly and in a structured manner. Participants will be able to contact the therapist when support and feedback is desired</description>
    <arm_group_label>Control of support and feedback</arm_group_label>
    <arm_group_label>Design of the CBT treatment content</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age 18 years and above&#xD;
&#xD;
          -  treatment for cardiovascular disease (CVD) according to European Society of Cardiology&#xD;
             guidelines&#xD;
&#xD;
          -  stable CVD (New York Heart Association class I-III) and not having been hospitalised&#xD;
             for CVD in in the last four weeks.&#xD;
&#xD;
          -  stress (Perceived Stress Scale (PSS)-10&gt;13 points) and/or&#xD;
&#xD;
          -  anxiety (i.e. General Anxiety Disorder Scale (GAD) â‰¥5 points) and/or&#xD;
&#xD;
          -  depressive symptoms (Patient Health Questionnaire-9 28 (PHQ-9) &gt; 5 points)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  severe CVD (New York Heart Association classification IV) or another severe chronic&#xD;
             life-threatening disease&#xD;
&#xD;
          -  severe stress, anxiety or depression assessed as requiring acute treatment&#xD;
&#xD;
          -  not being able to dedicate 3-4 hours per week to participate in the program&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Johansson, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Health, Medicine and Caring Sciences, Linkoping University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Peter Johansson, Ph.D</last_name>
    <phone>+46-070 08 96548</phone>
    <email>peter.b.johansson@liu.se</email>
  </overall_contact>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 22, 2021</study_first_submitted>
  <study_first_submitted_qc>January 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 27, 2021</study_first_posted>
  <last_update_submitted>January 25, 2021</last_update_submitted>
  <last_update_submitted_qc>January 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Linkoeping University</investigator_affiliation>
    <investigator_full_name>Peter Johansson</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Cardiovascular disease</keyword>
  <keyword>Psychological distress</keyword>
  <keyword>Internet-based cognitive behavioural therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Depression</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Our university works with the question of we can share IPD without violoating GPDR</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

